Tilray Initiates Roundtable With German Regulators to

BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and...

Related Keywords

United States ,Germany ,Portugal ,Australia ,New Zealand ,Canada ,Berlin ,America ,Canadian ,German ,Raphael Gross ,Burkhard Blienert ,Tilray Europe ,Carlos Kasper ,Denise Faltischek ,Berrin Noorata ,Martina Stamm Fibich ,Clemens Reisbeck ,Company Nasdaq ,Committee On ,Head Of International ,Ministry Of Health ,Committee On Health ,Nasdaq ,Securities Exchange ,Tilray Brands Inc ,German Drug Commissioner ,Narcotic Drugs ,Federal Ministry ,Drug Policy ,Chief Strategy Officer ,Tilray Brands ,Managing Director ,European Good Manufacturing Practice ,North America ,Tilray Medical ,Broken Coast ,Tilray Medical Europe ,Tilray Medical Canada ,Tilray Medical Australia ,Tilray Medical Australia New ,Latin America ,Securities Act ,Securities Exchange Act ,Annual Report ,Nasdaq Tlry ,Nc ,Europe Medical Cannabis ,Medical Cannabis ,Cannabis Legalization ,Cannabis Regulations ,Tilray ,U Gmp ,Dult Use Cannabis Germany ,